Terms: = Breast cancer AND Ki-67 AND Staging
111 results:
1. High tumor infiltrating lymphocytes are significantly associated with pathological complete response in triple negative breast cancer treated with neoadjuvant KEYNOTE-522 chemoimmunotherapy.
Wood SJ; Gao Y; Lee JH; Chen J; Wang Q; Meisel JL; Li X
Breast Cancer Res Treat; 2024 May; 205(1):193-199. PubMed ID: 38286889
[TBL] [Abstract] [Full Text] [Related]
2. Expression analysis of lymphocyte subsets and lymphocyte-to-monocyte ratio: reveling immunosuppression and chronic inflammation in breast cancer.
Zhang H; Li Y; Liu G; Chen X
J Cancer Res Clin Oncol; 2024 Jan; 150(1):28. PubMed ID: 38263363
[TBL] [Abstract] [Full Text] [Related]
3. Diagnostic yield of contrast-enhanced abdominal staging CT in patients with initially diagnosed breast cancer.
Jeong B; Lee YW; Lee SB; Kim J; Chung IY; Kim HJ; Ko BS; Lee JW; Son BH; Gwark S; Shin HJ; Yoo TK; Choi SH
Eur J Radiol; 2024 Feb; 171():111295. PubMed ID: 38241854
[TBL] [Abstract] [Full Text] [Related]
4. Evaluation of blood supply and metabolism in tumor, axillary lymph node and normal breast tissue with F-18 FDG PET/CT in breast cancer: comparison with pathological prognostic factors.
Abdulrezzak U; Akgun H; Tutus A; Kula M; Dogan S; Oz AB; Ok E
BMC Womens Health; 2024 Jan; 24(1):45. PubMed ID: 38229093
[TBL] [Abstract] [Full Text] [Related]
5. Calcium-Sensing Receptor Expression in breast cancer.
Busic-Pavlek I; Dumic-Cule I; Kovacevic L; Milosevic M; Delimar P; Korsa L; Marusic Z; Prutki M
Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511437
[TBL] [Abstract] [Full Text] [Related]
6. Analysis of the association of HER-2 low carcinomas and PAM50 assay in hormone receptor positive early-stage breast cancer.
Terán S; Alva M; Tolosa P; Rey-Cárdenas M; Madariaga A; Lema L; Ruano Y; Manso L; Ciruelos E; Sánchez-Bayona R
Breast; 2023 Oct; 71():42-46. PubMed ID: 37481795
[TBL] [Abstract] [Full Text] [Related]
7. Intermodal correlation of quantitative CT-data and MRI-biomarkers derived from synchronous spectral CT-maps and breast MRI-examinations with molecular biomarkers in invasive ductal breast carcinomas.
Klein K; Gabriel Schafigh D; Schömig-Markiefka B; Campbell GM; Weiss K; Malter W; Maintz D; Hellmich M; Barbara Krug K
Eur J Radiol; 2023 Aug; 165():110919. PubMed ID: 37302338
[TBL] [Abstract] [Full Text] [Related]
8. The roles of 68 Ga-PSMA PET/CT and 18 F-FDG PET/CT imaging in patients with triple-negative breast cancer and the association of tissue PSMA and claudin 1, 4, and 7 levels with PET findings.
Arslan E; Ergül N; Beyhan E; Erol Fenercioglu Ö; Sahin R; Cin M; Battal Havare S; Can Trabulus FD; Mermut Ö; Akbas S; Fikret Çermik T
Nucl Med Commun; 2023 Apr; 44(4):284-290. PubMed ID: 36756767
[TBL] [Abstract] [Full Text] [Related]
9. Contralateral lymph node metastasis in recurrent ipsilateral breast cancer with Lynch syndrome: a locoregional event.
Zwimpfer TA; Schwab FD; Steffens D; Kaul F; Schmidt N; Geiger J; Geissler F; Heinzelmann-Schwarz V; Weber WP; Kurzeder C
World J Surg Oncol; 2023 Feb; 21(1):40. PubMed ID: 36755294
[TBL] [Abstract] [Full Text] [Related]
10. Prognostic impact of
Park HL; Lee SW; Hong JH; Lee J; Lee A; Kwon SJ; Park SY; Yoo IR
Cancer Imaging; 2023 Jan; 23(1):2. PubMed ID: 36600314
[TBL] [Abstract] [Full Text] [Related]
11. [Pretreatment evaluation of
Peng P; Wu N; Tao XL; Liu Y; Lyu L; Cheng X
Zhonghua Zhong Liu Za Zhi; 2022 Apr; 44(4):370-376. PubMed ID: 35448927
[No Abstract] [Full Text] [Related]
12. Prognostic Utility of the ki-67 Labeling Index in Follicular Thyroid Tumors: a 20-Year Experience from a Tertiary Thyroid Center.
Hellgren LS; Stenman A; Paulsson JO; Höög A; Larsson C; Zedenius J; Juhlin CC
Endocr Pathol; 2022 Jun; 33(2):231-242. PubMed ID: 35305239
[TBL] [Abstract] [Full Text] [Related]
13. Preoperative Ultrasound-guided Sub-areolar Biopsy in Predicting Occult Nipple Involvement in breast cancer Patients: Proposal for a Methodological Approach.
Altomare V; Orsaria P; Grasso A; Caggiati L; Ippolito E; Pantano F; Sammarra M; Altomare C; Perrone G; Gullotta G; Carino R
In Vivo; 2022; 36(2):839-847. PubMed ID: 35241540
[TBL] [Abstract] [Full Text] [Related]
14. Comparison of Ultrasound Features With Maximum Standardized Uptake Value Assessed by 18F-Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography for Prognosis of Estrogen Receptor+/Human Epithelial Growth Factor Receptor 2- breast cancer.
Choi B
Ultrasound Q; 2021 Nov; 38(1):18-24. PubMed ID: 35239627
[TBL] [Abstract] [Full Text] [Related]
15. Relationships of
Sengoz T; Karakaya YA; Gultekin A; Yaylali O; Senol H; Yuksel D
Rev Esp Med Nucl Imagen Mol (Engl Ed); 2022; 41(1):32-38. PubMed ID: 34991834
[TBL] [Abstract] [Full Text] [Related]
16. Association of
Önner H; Coskun N; Erol M; Eren Karanis Mİ
Rev Esp Med Nucl Imagen Mol (Engl Ed); 2022; 41(1):11-16. PubMed ID: 34991831
[TBL] [Abstract] [Full Text] [Related]
17. TTK predicts triple positive breast cancer prognosis and regulates tumor proliferation and invasion.
Gao YH; Qu SS; Cao LQ; Yao M
Neoplasma; 2022 Mar; 69(2):274-282. PubMed ID: 34846157
[TBL] [Abstract] [Full Text] [Related]
18. Association between systemic immune-inflammation index and neoadjuvant chemotherapy efficacy as well as prognosis in triple-negative breast cancer.
Pang J; Wang S; Liao L; Liu X
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2021 Sept 28; 46(9):958-965. PubMed ID: 34707005
[TBL] [Abstract] [Full Text] [Related]
19. Multicenter retrospective study on the use of Curebest™ 95GC breast for estrogen receptor-positive and node-negative early breast cancer.
Tsukamoto F; Arihiro K; Takahashi M; Ito KI; Ohsumi S; Takashima S; Oba T; Yoshida M; Kishi K; Yamagishi K; Kinoshita T
BMC Cancer; 2021 Oct; 21(1):1077. PubMed ID: 34610807
[TBL] [Abstract] [Full Text] [Related]
20. Association Between Metabolic Syndrome and Immunohistochemical Profile at breast cancer Diagnosis in Postmenopausal Women.
Motoki AH; Buttros DAB; Gaspar AL; Almeida-Filho BS; Carvalho-Pessoa E; Vespoli HDL; Nahas-Neto J; Nahas EAP
Clin Breast Cancer; 2022 Feb; 22(2):e253-e261. PubMed ID: 34465534
[TBL] [Abstract] [Full Text] [Related]
[Next]